Incyte Corp (NAS:INCY)
$ 69.91 0.07 (0.1%) Market Cap: 13.47 Bil Enterprise Value: 11.73 Bil PE Ratio: 499.36 PB Ratio: 4.25 GF Score: 89/100

Incyte Corp at RBC Capital Markets Healthcare Conference Transcript

May 21, 2019 / 02:30PM GMT
Release Date Price: $78.68 (+2.41%)
Brian Corey Abrahams
RBC Capital Markets, LLC, Research Division - Senior Analyst

We're really pleased to have our next presenting company here, Incyte, represented by their President and CEO, Hervé Hoppenot. Hervé?

HervÃ;Hoppenot
Incyte Corporation - Chairman, President & CEO

© -

Thank you. Thank you for inviting us.

Brian Corey Abrahams
RBC Capital Markets, LLC, Research Division - Senior Analyst

Thank you so much. Really appreciate it. A lot to cover. So yes, just -- let's get started.

Questions & Answers

Brian Corey Abrahams;HervÃ;Hoppenot
RBC Capital Markets, LLC, Research Division - Senior Analyst;

Maybe kicking off with GVHD since that's the next potential data point and catalyst that we're going to hear about. Can you -- maybe you could tell us a little bit more in terms of background on the GVHD program. And in particular, the Jakafi PDUFA date is coming up very soon push back to...

©

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot